Publications by authors named "S Skrede"
Article Synopsis
- Graphene is a special material made of carbon atoms and could be useful in medicine, but we need to check how safe it is for living things.
- We compared two ways to make graphene: one method (sonication) gave us more toxic graphene, while the other method (microfluidization) produced safer graphene.
- In tests with blood and zebrafish larvae, we found that sonicated graphene was much more harmful than microfluidized graphene, which was less toxic and caused fewer changes in immune cell behavior.
Background: Streptococcus dysgalactiae subspecies equisimilis (SDSE) is increasingly recognized as an emerging cause of invasive diseases including necrotizing soft tissue infections (NSTIs). In contrast to the closely related Streptococcus pyogenes, SDSE infections mainly affect older and comorbid patients. Biofilm formation has been demonstrated in soft tissue biopsies of S.
View Article and Find Full Text PDFBackground: (SD) is an important pathogen in humans as well as in a broad range of animal species. Escalating rates of antibiotic resistance in SD has been reported in both human and veterinary clinical practice, but the dissemination of resistance determinants has so far never been examined in a One Health Perspective. We wanted to explore the occurrence of zoonotic transmission of SD and the potential for exchange of resistance traits between SD from different host populations.
View Article and Find Full Text PDFBackground: Patients with multiple sclerosis (MS) treated with anti-CD20 therapies such as rituximab may have increased risk of severe COVID-19 disease. Vaccination induces protective immunity, but humoral vaccine response is known to be attenuated in rituximab-treated MS-patients-patients, which has indicated a need for real world data on severe morbidity and mortality from COVID-19 after vaccination.
Methods: Rituximab-treated patients treated at Haukeland University Hospital were identified through the National MS Registry and invited to participate in the study by giving a consent and providing a blood sample 3 weeks or later after ordinary COVID-19- vaccination, i.